MAQS has advised IRLAB Therapeutics AB. IRLAB Therapeutics AB has been admitted to trading the Company’s shares of series A on Nasdaq Stockholm Main Market. IRLAB…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
